> Details

Vanover, Kimberly E.; Weiner, David M.; Makhay, Malath; Veinbergs, Isaac; Gardell, Luis R.; Lameh, Jelveh; Del Tredici, Andria L.; Piu, Fabrice; Schiffer, Hans H.; Ott, Thomas R.; Burstein, Ethan S.; Uldam, Allan K.; Thygesen, Mikkel B.; Schlienger, Nathalie; Andersson, Carl Magnus; Son, Thomas Y.; Harvey, Scott C.; Powell, Susan B.; Geyer, Mark A.; Tolf, Bo-Ragner; Brann, Mark R.; Davis, Robert E.

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist
  • Contributor: Vanover, Kimberly E.; Weiner, David M.; Makhay, Malath; Veinbergs, Isaac; Gardell, Luis R.; Lameh, Jelveh; Del Tredici, Andria L.; Piu, Fabrice; Schiffer, Hans H.; Ott, Thomas R.; Burstein, Ethan S.; Uldam, Allan K.; Thygesen, Mikkel B.; Schlienger, Nathalie; Andersson, Carl Magnus; Son, Thomas Y.; Harvey, Scott C.; Powell, Susan B.; Geyer, Mark A.; Tolf, Bo-Ragner; Brann, Mark R.; Davis, Robert E.
  • imprint: American Society for Pharmacology & Experimental Therapeutics (ASPET), 2006
  • Published in: Journal of Pharmacology and Experimental Therapeutics
  • Language: English
  • DOI: 10.1124/jpet.105.097006
  • ISSN: 0022-3565; 1521-0103
  • Origination:
  • Footnote: